| NCT ID | NCT05842551 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituti Clinici Scientifici Maugeri SpA |
| Condition | Stroke, Ischemic |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2023-03-07 |
| Primary Completion | 2026-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2023-03-07 with a primary completion date of 2026-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to to evaluate the effect and feasibility of a rehabilitation protocol with prismatic lenses associated with tDCS, compared to a prismatic lens rehabilitation protocol associated with sham stimulation, in reducing the signs of neglect in a group of patients with spatial heminegligence following ischemic stroke of the right hemisphere. The secondary objective is to evaluate the impact of this rehabilitation protocol on functional outcome.
Eligibility Criteria
Inclusion Criteria: * age \>18 years * ischemic stroke * hospitalization within 90 days of the event Exclusion Criteria: * heamorrhagic stroke * history of neurological disease * history of psychiatric disease * use of alchool and drugs
Contact & Investigator
Simona Spaccavento
PRINCIPAL INVESTIGATOR
Istituti Clinici Scientifici Maugeri
Frequently Asked Questions
Who can join the NCT05842551 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Stroke, Ischemic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05842551 currently recruiting?
Yes, NCT05842551 is actively recruiting participants. Contact the research team at simona.spaccavento@icsmaugeri.it for enrollment information.
Where is the NCT05842551 trial being conducted?
This trial is being conducted at Bari, Italy.
Who is sponsoring the NCT05842551 clinical trial?
NCT05842551 is sponsored by Istituti Clinici Scientifici Maugeri SpA. The principal investigator is Simona Spaccavento at Istituti Clinici Scientifici Maugeri. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.